SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Usana Health Sciences Inc – ‘SC14D9C’ on 5/20/08 re: Usana Health Sciences Inc

On:  Tuesday, 5/20/08, at 6:34pm ET   ·   As of:  5/21/08   ·   Accession #:  1157523-8-4457   ·   File #:  5-55565

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 5/21/08  Usana Health Sciences Inc         SC14D9C     5/20/08    2:7K   Usana Health Sciences Inc         Business Wire/FA

Tender-Offer Solicitation/Recommendation Statement — Preliminary Communication   —   Schedule 14D-9C
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC14D9C     Usana Health Sciences, Inc. SC14D9C                    2      7K 
 2: EX-99.1     Miscellaneous Exhibit                                  2±     9K 


SC14D9C   —   Usana Health Sciences, Inc. SC14D9C

SC14D9C1st Page of 2TOCTopPreviousNextBottomJust 1st
 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ------------ SCHEDULE 14D-9 SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 ------------ USANA HEALTH SCIENCES, INC. (Name of Subject Company) USANA HEALTH SCIENCES, INC (Name of Person(s) Filing Statement) ------------ Common Stock, $0.001 par value (Title of Class of Securities) ------------ 90328M107 (CUSIP Number of Class of Securities) ------------ Gilbert A. Fuller Executive Vice President and Chief Financial Officer USANA Health Sciences, Inc. 3838 West Parkway Boulevard Salt Lake City, Utah 84120 Telephone: (801) 954-7100 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications on Behalf of the Person(s) Filing Statement) With a copy to: Robert M. Mattson, Jr. Morrison & Foerster LLP 425 Market Street San Francisco, CA 94105-2482 (415) 268-7000 |X| Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.
SC14D9CLast Page of 2TOC1stPreviousNextBottomJust 2nd
On May 20, 2008, USANA Health Sciences, Inc. (the "Company") issued a press release announcing that its Board of Directors has formed a Special Committee of independent directors to evaluate and respond to any offer received from Gull Holdings, Ltd. and the other tender offer participants to acquire all of the outstanding shares of the Company that Gull Holdings and the other tender offer participants do not already own, as announced in Schedule TO under Section 14d-1 or Section 13(e)(1), filed with the Securities and Exchange Commission by Gull Holdings and the other tender offer participants on May 13, 2008. A copy of the Company's press release is attached as Exhibit 99.1 to this Schedule 14D-9. Exhibit No. Description 99.1 Press release dated May 20, 2008. 2

Dates Referenced Herein   and   Documents Incorporated by Reference

Referenced-On Page
This ‘SC14D9C’ Filing    Date First  Last      Other Filings
Filed as of:5/21/084
Filed on:5/20/082SC 13D,  SC 14D9
5/13/0823,  SC TO-C
 List all Filings 
Top
Filing Submission 0001157523-08-004457   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 15, 2:17:34.2pm ET